JP3135295B2 - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JP3135295B2
JP3135295B2 JP03195986A JP19598691A JP3135295B2 JP 3135295 B2 JP3135295 B2 JP 3135295B2 JP 03195986 A JP03195986 A JP 03195986A JP 19598691 A JP19598691 A JP 19598691A JP 3135295 B2 JP3135295 B2 JP 3135295B2
Authority
JP
Japan
Prior art keywords
skin
alcohol
saikosaponin
external preparation
saikosaponins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP03195986A
Other languages
Japanese (ja)
Other versions
JPH0517335A (en
Inventor
敏夫 西山
信子 圷
雅昭 斉藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP03195986A priority Critical patent/JP3135295B2/en
Publication of JPH0517335A publication Critical patent/JPH0517335A/en
Application granted granted Critical
Publication of JP3135295B2 publication Critical patent/JP3135295B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、皮膚外用剤に係わり、
更に詳しくは皮膚細胞増殖効果の高い皮膚外用剤に関す
る。本皮膚外用剤は、例えば、化粧水、クリーム、乳
液、パック、頭皮用化粧料等の化粧品や、例えば、傷治
療、消炎用軟膏等の医薬品に好適に適用される。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation,
More specifically, it relates to a skin external preparation having a high skin cell proliferation effect. The external preparation for skin is suitably applied to cosmetics such as lotions, creams, emulsions, packs, cosmetics for scalp, and pharmaceuticals such as wound treatments and anti-inflammatory ointments.

【0002】[0002]

【従来の技術】柴胡等の植物から抽出されるサイコサポ
ニンは、皮膚の創傷治癒、肌あれ防止及び改善、皮膚の
たるみやつや消失を防ぐ老化防止等の効果があり、医薬
品、化粧品等に配合されている。
2. Description of the Related Art Psychosaponins extracted from plants such as Saiko have the effects of healing wounds on the skin, preventing and improving skin roughness, and preventing aging that prevents sagging and disappearance of the skin. It is blended.

【0003】また、抽出されたサイコサポニンを、サイ
コサポニンa、サイコサポニンb1、サイコサポニン
2、サイコサポニンc、サイコサポニンdに分離し、
各成分を単独で用いることにより上記効果を高めた技術
も提案されている(特開昭61−7216号公報)。
Further, the extracted saikosaponin is separated into saikosaponin a, saikosaponin b 1 , saikosaponin b 2 , saikosaponin c, and saikosaponin d,
A technique in which the above effects are enhanced by using each component alone has been proposed (JP-A-61-7216).

【0004】しかるに、これらよりもより一層上記効果
を高めた皮膚外用剤がのぞまれている。
[0004] However, external preparations for the skin that further enhance the above effects are desired.

【0005】一方、サイコサポニンb1およびサイコサ
ポニンb2を含有する外用剤は、長期間放置すると系が
不安定になり上記した効果が低下するため、経時的にも
安定な皮膚外用剤が望まれている。
On the other hand, an external preparation containing saikosaponin b 1 and saikosaponin b 2 becomes unstable when left standing for a long period of time, and the above-mentioned effects are reduced. It is rare.

【0006】[0006]

【発明が解決しようとする課題】以上の状況の中で、本
発明は、皮膚の創傷治癒、肌荒れ防止及び改善、皮膚の
たるみやつや消失を防ぐ老化防止等の効果を従来よりも
一層改善し、しかも系を安定させ、上記効果を長期間に
わたって、持続できる皮膚外用剤を提供することを目的
とする。
SUMMARY OF THE INVENTION Under the above circumstances, the present invention has improved the effects of healing the skin, preventing and improving the rough skin, and preventing the aging of the skin from sagging and disappearing. In addition, an object of the present invention is to provide a skin external preparation that stabilizes the system and can maintain the above-mentioned effects for a long period of time.

【0007】[0007]

【課題を解決するための手段】本発明の第1の要旨はサ
イコサポニンb1及びb2の少なくとも1種とバチルアル
コールを含有することを特徴とする皮膚外用剤に存在す
る。
The first aspect of the present invention resides in an external preparation for skin characterized by containing at least one of saikosaponins b 1 and b 2 and batyl alcohol.

【0008】第2の要旨は、第1の要旨において、サイ
コサポニンb1及びb2の少なくとも1種を0.0001
〜20重量%含むことを特徴とする皮膚外用剤に存在す
る。第3の要旨は、第1または2の要旨において、前記
バチルアルコールを0.01〜20重量%含むことを特
徴と皮膚外用剤に存在する。
A second aspect is the first aspect, wherein at least one of saikosaponins b 1 and b 2 is 0.0001
About 20% by weight. A third aspect of the present invention resides in the external preparation for skin according to the first or the second aspect, characterized in that the composition comprises 0.01 to 20% by weight of the batyl alcohol.

【0009】[0009]

【作用】以下に本発明の作用を詳述する。The operation of the present invention will be described below in detail.

【0010】本発明の皮膚外用剤においては、サイコサ
ポニンb1とサイコサポニンb2の少なくともどちらかが
配合される。配合量は、皮膚外用剤全量中0.0001
〜20重量%が好ましく、0.001〜10重量%がよ
り好ましい。0.001重量%以上で皮膚の創傷治癒、
肌荒れ防止及び改善、皮膚のたるみやつや消失を防ぐ老
化防止等の効果は一層向上する。また、10%重量以下
では、べたつき感や刺激性が一層なくなる等の効果が生
じる。
[0010] In the skin external preparation of the present invention, at least one of saikosaponins b 1 and saikosaponins b 2 is blended. The compounding amount is 0.0001 in the total amount of the external preparation for skin.
-20% by weight is preferable, and 0.001-10% by weight is more preferable. Wound healing of the skin at 0.001% by weight or more,
The effects of preventing and improving skin roughness and preventing aging, which prevents sagging and loss of skin, are further improved. When the weight is 10% or less, effects such as a further decrease in sticky feeling and irritation are produced.

【0011】本発明において、バチルアルコールの配合
量は、皮膚外用剤全量中0.01〜20重量%が好まし
く、0.5〜8重量%がより好ましい。0.5%以上で
皮膚の創傷治癒、肌荒れ防止及び改善、皮膚のたるみや
つや消失を防ぐ老化防止等の効果が一層向上し、しかも
系の安定性はより一層向上し、長期間にわたり上記効果
は維持される。8重量%以下で、べたつき感が更になく
なり、さっぱりとした使用感がより一層向上する。
In the present invention, the compounding amount of batyl alcohol is preferably 0.01 to 20% by weight, more preferably 0.5 to 8% by weight, based on the total amount of the external preparation for skin. At 0.5% or more, the effects of wound healing of the skin, prevention and improvement of skin roughness, anti-aging to prevent sagging and loss of skin, and the like, are further improved, and the stability of the system is further improved, and the above effects are obtained over a long period of time. Is maintained. When the content is 8% by weight or less, the sticky feeling is further reduced, and the refreshing feeling of use is further improved.

【0012】本発明の皮膚外用剤は、上記の必須成分に
加えて、本発明の効果を損なわない範囲で、化粧品、医
薬品等に用いられる成分、例えば、水性成分、粉末成
分、油分、界面活性剤、保湿剤、増粘剤、防腐剤、酸化
防止剤、香料、色剤及び薬剤等を配合することができ
る。
The external preparation for skin of the present invention may contain, in addition to the above essential components, components used in cosmetics and pharmaceuticals, such as aqueous components, powder components, oil components, and surface active agents, as long as the effects of the present invention are not impaired. An agent, a humectant, a thickener, a preservative, an antioxidant, a fragrance, a coloring agent, a drug and the like can be compounded.

【0013】[0013]

【実施例】次に実施例をあげて本発明を詳細に説明する
が、本発明の技術範囲がこれら実施例に限定されるもの
でないことはいうまでもない。
EXAMPLES Next, the present invention will be described in detail with reference to examples, but it goes without saying that the technical scope of the present invention is not limited to these examples.

【0014】まず、サイコサポニンb1及びb2の皮膚の
創傷治癒、肌あれ防止及び改善、皮膚のたるみやつや消
失を防ぐ老化防止等の効果及び使用感が、バチルアルコ
ールを配合することにより相乗的に改善され、しかもこ
れら効果が長期間にわたり持続することを示すために、
(a)サイコサポニンb1あるいはb2の水溶液及び
(b)サイコサポニンb1あるいはb2とバチルアルコー
ルを含む水溶液を作製し、皮膚細胞増殖促進効果、創傷
治癒効果及び刺激性(溶血)抑制効果について以下の試
験を行い、これら効果及び経時変化を調べた。
First, the effects of saikosaponins b 1 and b 2 , such as wound healing of the skin, prevention and improvement of skin roughness, anti-aging that prevents sagging and loss of skin, and the feeling of use, are synergistically achieved by blending batyl alcohol. In order to show that these effects have been improved over time and that these effects last for a long time,
(A) to prepare an aqueous solution containing saikosaponins b 1 or an aqueous solution and (b) saikosaponins b 1 or b 2 and batyl alcohol b 2, skin cell growth-promoting effects, wound healing effect and irritation (hemolysis) inhibiting effect The following tests were carried out on the samples, and their effects and changes over time were examined.

【0015】(皮膚細胞増殖促進作用) 1)細胞増殖効果 人皮膚組織を細片し、細胞培養用シャーレの底面に付着
させてDulbecco's MEM培養液(10%牛胎児血清含
有)中で2週間培養すると、シャーレの底面がほぼ全面
に線維芽細胞で満たされる。この線維芽細胞を0.1%
トリプシン溶液で処理して単一細胞とし、1000個細
胞/mlの培養液をつくる。この溶液をシャーレ当り1
ml採取し、これにDulbecco'sMEM培養液とサイコサポ
ニンb1を加え、または更にバチルアルコールを100
ppm加え、CO2−インキュベーター中で2週間培養
した。その後、細胞固定して染色した後、細胞のコロニ
ー数を計測した。結果を図1に示す。
(Skin cell proliferation promoting action) 1) Cell proliferation effect A human skin tissue is sliced, adhered to the bottom of a cell culture dish, and cultured in Dulbecco's MEM culture medium (containing 10% fetal bovine serum) for 2 weeks. Then, the bottom surface of the Petri dish is almost entirely filled with fibroblasts. 0.1% of these fibroblasts
The cells are treated with a trypsin solution to form single cells, and a culture solution of 1000 cells / ml is prepared. This solution is added 1 per petri dish
and ml collected, which in the Dulbecco'sMEM culture and saikosaponins b 1 In addition, or even a batyl alcohol 100
ppm addition, CO 2 - and cultured for 2 weeks in an incubator. Thereafter, the cells were fixed and stained, and the number of cell colonies was counted. The results are shown in FIG.

【0016】図1の実線は、培養液にサイコサポニンb
1を加えた場合の細胞増殖率であり、破線は(実施
例)、更にバチルアルコールを加えた場合の細胞増殖率
である。図の細胞増殖率は、サイコサポニンb1を添加
しない場合の細胞数を基準とし、それに対する比で表し
た。
The solid line in FIG. 1 indicates that saikosaponin b
The cell growth rate when 1 is added, and the broken line (Example) is the cell growth rate when further adding batyl alcohol. Cell proliferation rate figure, with respect to the number of cells without the addition of saikosaponins b 1, expressed by the ratio thereto.

【0017】2)細胞増殖効果の持続性 (a)サイコサポニンb1の0.01%水溶液及び
(b)サイコサポニンb10.01%とバチルアルコー
ル0.01%を含む水溶液を作製し、室温で放置した。
[0017] 2) to prepare an aqueous solution containing a persistent (a) Psycho 0.01% aqueous solution and the saponin b 1 (b) saikosaponins b 1 0.01% and batyl 0.01% alcohol of cell proliferation effect, Leave at room temperature.

【0018】1)と同様にして培養液を作製し、これに
サイコサポニンb1濃度が20ppmとなるように
(a)あるいは(b)の水溶液を加え、同様にして細胞
のコロニー数を計測した。結果を図に示す。
[0018] 1) and in the same manner to prepare a culture solution, this way saikosaponins b 1 concentration of 20ppm an aqueous solution of (a) or (b) was added, the number of colonies was counted cells in the same manner . The results are shown in the figure.

【0019】図1の実線は、培養液に(a)の水溶液を
加えた場合の結果であり、破線(実施例)は、(b)の
水溶液を加えた場合の結果である。
The solid line in FIG. 1 shows the result when the aqueous solution of (a) was added to the culture solution, and the broken line (Example) shows the result when the aqueous solution of (b) was added.

【0020】また図の細胞増殖率は、(a)及び(b)
の水溶液を作製直後に行った試験での細胞のコロニー数
を基準とし、それに対する比で表した。
The cell growth rates in the figures are (a) and (b)
The aqueous solution of was used as a reference, and the ratio was expressed relative to the number of colonies of cells in a test performed immediately after the preparation.

【0021】図1及び2から明らかなように、バチルア
ルコールを添加することにより、細胞増殖率は大幅に増
加した。更に2000時間経過後であっても細胞増殖効
果はほとんど低下せず、効果が持続することを示した。
それに対し、バチルアルコールを含んでいない試料で
は、経時的に細胞増殖効果が減少した。
As is clear from FIGS. 1 and 2, the addition of batyl alcohol greatly increased the cell growth rate. Furthermore, even after lapse of 2,000 hours, the cell proliferation effect hardly decreased, indicating that the effect was maintained.
On the other hand, in the sample containing no batyl alcohol, the cell growth effect decreased over time.

【0022】この結果は、サイコサポニンb2について
も、同様に得られた。
[0022] The results, also saikosaponin b 2, was obtained in the same manner.

【0023】(創傷治癒効果) (a)サイコサポニンb1を200mgあるいは(b)
サイコサポニンb1200mgとバチルアルコール10
0mgを生理食塩水1mlに溶解した試料を作製し室温
で放置した。
[0023] (wound healing effect) (a) a psycho saponin b 1 200mg or (b)
200 mg of saikosaponin b 1 and batyl alcohol 10
A sample in which 0 mg was dissolved in 1 ml of physiological saline was prepared and allowed to stand at room temperature.

【0024】生後6週間のウイスター系ラット5匹を1
群とし、毛刈りの後試験に供した。ラットはネンプター
ルにより麻酔後、正中線に沿って背部皮膚を約2cm切
開した、直ちに切開部をミツヘル縫合し、(a)及び
(b)の水溶液を生理食塩水で1000分の1に希釈し
た水溶液を1日1回2週間塗布した。2週間後に縫合針
を外し、断面1cmとなるように皮膚切片を作製した。
この切片の切断張力を東洋測器株式会社製テンシロンU
TM−4を用いて測定した。結果を表1にまとめた。
Five Wistar rats, 6 weeks old, were
Groups were cut and subjected to a test after shearing. The rat was anesthetized with Nemptal and then the back skin was incised about 2 cm along the midline. Immediately the incision was sutured with a Mitsuheru, and the aqueous solutions of (a) and (b) were diluted to 1 / 1,000 with physiological saline. Was applied once a day for 2 weeks. Two weeks later, the suture needle was removed, and a skin section was prepared so as to have a cross section of 1 cm.
The cutting tension of this section was measured by Tensilon U manufactured by Toyo Sokki Co., Ltd.
It measured using TM-4. The results are summarized in Table 1.

【0025】[0025]

【表1】 表1が示すように、バチルアルコールを添加すること
により、サイコサポニンb1の創傷治癒効果は著しく向
上し、また経時的安定性も極めて高くなることが分かっ
た。サイコサポニンb2についても同様に良好な結果が
得られた。
[Table 1] As Table 1 shows, by adding batyl alcohol, wound healing effect of saikosaponins b 1 is remarkably improved, also was found that even very high stability over time. Similarly good results for saikosaponins b 2 was obtained.

【0026】(刺激性抑制試験)人の血液から赤血球を
採取し、サイコサポニンb1あるいはサイコサポニンb1
とバチルアルコールを加えて1時間放置し、溶血量を測
定した。結果を図3に示す。図が示すように、バチルア
ルコールを添加することにより、溶血作用は高濃度まで
抑制されることが分かった。また、溶血作用に、経時変
化がないことも確認した。
(Irritation Suppression Test) Erythrocytes are collected from human blood and saikosaponin b 1 or saikosaponin b 1
And batyl alcohol were added and left for 1 hour, and the amount of hemolysis was measured. The results are shown in FIG. As shown in the figure, it was found that the addition of batyl alcohol suppressed the hemolytic action to a high concentration. It was also confirmed that the hemolytic action did not change over time.

【0027】(実施例1及び比較例1)エタノールに、
サイコサポニンb2、バチルアルコール及び香料を加え
て溶解し、アルコール相を作製した。イオン交換水及び
クインスシード抽出液を除く他の成分を混合し、70℃
で加熱溶解することにより油相を作製した。
(Example 1 and Comparative Example 1)
Psychosaponin b 2 , batyl alcohol and a flavor were added and dissolved to prepare an alcohol phase. Mix other components except ion-exchanged water and quince seed extract,
By heating and dissolving in, an oil phase was prepared.

【0028】次に、70℃に加熱したイオン交換水に油
相を加え予備乳化を行い、続いてホモミキサーで均一に
乳化した。攪拌しながら乳化液にアルコール相とクイン
スシード抽出液を加え、30℃に冷却して表2組成の乳
液を作製した。比較例1として、バチルアルコールを添
加しない乳液も併せて作製した。
Next, the oil phase was added to ion-exchanged water heated to 70 ° C. to carry out preliminary emulsification, and then homogenized uniformly with a homomixer. The alcohol phase and the quince seed extract were added to the emulsion while stirring, and the emulsion was cooled to 30 ° C. to prepare an emulsion having the composition shown in Table 2. As Comparative Example 1, an emulsion without the addition of batyl alcohol was also prepared.

【0029】[0029]

【表2】 試料1〜4は本発明の実施例、試料5は比較例1であ
る。このうち、試料1及び2は請求項2及び3を満たす
実施例、試料3及び4は請求項3を満たす実施例であ
る。
[Table 2] Samples 1 to 4 are Examples of the present invention, and Sample 5 is Comparative Example 1. Of these, samples 1 and 2 are embodiments satisfying claims 2 and 3, and samples 3 and 4 are embodiments satisfying claim 3.

【0030】試料1〜5の乳液を用い、人体パネルで肌
荒れ改善効果試験を行った。また、べたつき感、刺激性
等の使用感試験も併せて行った。結果を表4に示す。な
お、試験方法は以下の通りである。
Using the emulsions of Samples 1 to 5, a skin roughness improvement effect test was conducted on a human body panel. In addition, use feeling tests such as stickiness and irritation were also performed. Table 4 shows the results. The test method is as follows.

【0031】肌荒れ改善効果試験 女性健常人の顔面表面形態をミリスン樹脂によるレプリ
カ法を用いて肌のレプリカを取り、顕微鏡で観察する。
皮紋の状態及び角層の剥離状態から表3の基準に基づい
て肌あれ状態「1」あるいは「2」と評価されたパネル
25名の顔面左右半々に実施例と比較例1の乳液を1日
1回2週間塗布した。
Skin roughness improvement effect test The replica of the skin of a healthy female subject is morphologically observed by a replica method using a millisin resin and observed with a microscope.
The emulsions of Example and Comparative Example 1 were applied to the left and right half of the face of 25 panels evaluated as having rough skin condition “1” or “2” based on the criteria in Table 3 based on the condition of the skin pattern and the peeling condition of the stratum corneum. It was applied once a day for 2 weeks.

【0032】2週間後、再び上記のレプリカ法で肌の状
態を観察し、表3の基準に従い肌の状態を評価した。
After two weeks, the condition of the skin was observed again by the replica method described above, and the condition of the skin was evaluated according to the criteria shown in Table 3.

【0033】使用感(べたつき、刺激性)試験 25名のテスターが上記乳液を塗布し、そのべたつき
性、刺激性について官能評価した。各々の試料につい
て、べたつきや刺激を感じた人数を示す。
Usability (stickiness, irritation) test 25 testers applied the above emulsions, and evaluated the stickiness and irritation organoleptically. For each sample, the number of people who felt stickiness or irritation was shown.

【0034】[0034]

【表3】 [Table 3]

【0035】[0035]

【表4】 表4が示すように、比較例の試料5に比べ本実施例の
乳液はいずれも肌あれ改善効果が向上し、特に、請求項
2及び3を満たす試料1及び2は極めて良好な肌荒れ改
善効果と高い使用感を示した。
[Table 4] As shown in Table 4, all of the emulsions of the present example have improved skin roughness improvement effects compared to Sample 5 of Comparative Example, and Samples 1 and 2 satisfying Claims 2 and 3 have particularly excellent skin roughness improvement effects. And showed a high usability.

【0036】また、サイコサポニンb1含有量が0.0
001重量%より少ない試料3では刺激性やべたつき感
はないものの、肌荒れ改善効果が試料1及び2に比べ劣
っていた。サイコサポニンb1含有量が20%を越える
試料4は、良好な肌荒れ改善効果を示したが、べたつき
感が現れることが分かった。
When the saikosaponin b 1 content is 0.0
Sample 3 having less than 001% by weight had no irritation or stickiness, but was inferior to samples 1 and 2 in improving skin roughness. Sample 4 having a saikosaponin b 1 content of more than 20% exhibited a good effect of improving rough skin, but it was found that a sticky feeling appeared.

【0037】(実施例2)実施例1の試料1と同様にし
て、種々の濃度のバチルアルコールを含有する乳液を作
製した。バチルアルコール含有量の変化分はイオン交換
水で相殺し、他の成分含有量は実施例1の試料1と同量
とした。ここで本実施例の試料6のバチルアルコール含
有量は15%、試料7は0.005%、試料8は22%
である。
Example 2 In the same manner as in Sample 1 of Example 1, emulsions containing various concentrations of batyl alcohol were prepared. The change in the content of batyl alcohol was offset by ion-exchanged water, and the content of the other components was the same as in Sample 1 of Example 1. Here, the batyl alcohol content of the sample 6 of this example is 15%, the sample 7 is 0.005%, and the sample 8 is 22%.
It is.

【0038】得られた試料について、(1)作製直後及
び(2)50℃の恒温室に6カ月放置後に、人体パネル
で肌荒れ改善効果試験を行い、肌荒れ改善効果の経時安
定性を調べた。結果を表5に示す。
With respect to the obtained samples, (1) immediately after preparation and (2) after standing in a constant temperature room at 50 ° C. for 6 months, a skin roughness improvement effect test was performed on a human body panel to examine the stability over time of the skin roughness improvement effect. Table 5 shows the results.

【0039】[0039]

【表5】 表5が示すように、50℃の恒温槽に6カ月放置した試
料5(比較例)の乳液は、その肌荒れ効果が大きく低下
したのに対し、本実施例の乳液は肌荒れ改善効果が経時
的に安定であることを分かる。特に請求項3を満たす実
施例の試料1及び6は、高い肌荒れ改善効果の持続性を
示した。バチルアルコール濃度が0.01%より少ない
試料7については、請求項3を満たす試料1や6に比
べ、肌荒れ改善効果の持続性は劣るが、バチルアルコー
ルを含まない比較例に比べ経時的に安定であった。ま
た、バチルアルコールが20%を越える試料8は高い肌
荒れ改善効果及びその経時的安定性を示すが、べたつき
感が現れ使用感が悪いことが分かった。
[Table 5] As shown in Table 5, the emulsion of Sample 5 (Comparative Example) left in a thermostat at 50 ° C. for 6 months had a significantly reduced skin roughness effect, whereas the emulsion of the present Example had a time-dependent improvement in skin roughness improvement effect. It turns out that it is stable. In particular, Samples 1 and 6 of Examples satisfying claim 3 exhibited a high persistence of the rough skin improvement effect. Sample 7 having a batyl alcohol concentration of less than 0.01% is inferior in the effect of improving skin roughness as compared with Samples 1 and 6 satisfying claim 3, but is more stable over time than the comparative example containing no batyl alcohol. Met. In addition, it was found that Sample 8 containing more than 20% of batyl alcohol exhibited a high skin roughness improvement effect and its stability over time, but showed a sticky feeling and a poor feeling of use.

【0040】(実施例3〜7)以下の各実施例に示した
組成、製法に基づき作製した皮膚外用剤は従来例に比
べ、いずれの場合も、肌荒れ改善効果あるいは創傷治癒
効果が向上した。また、これら効果の経時的安定性が改
善された。
(Examples 3 to 7) In each case, the external preparation for skin prepared based on the composition and the production method shown in each of the following examples improved the effect of improving the rough skin or the effect of healing the wound as compared with the conventional example. In addition, the stability over time of these effects was improved.

【0041】(実施例3) 化粧水 重量% (アルコール相) サイコサポニンb1 0.05 バチルアルコール 4.0 エタノール 7.0 ポリオキシエチレンオレイルアルコール 0.6 メチルパラベン 0.05 香料 0.05 (水相) グリセリン 4.0 クエン酸 0.01 クエン酸ナトリウム 0.1 イオン交換水 84.14 (製法)水相及びアルコール相をそれぞれ調製し、こ
れらを混合可溶化した後、ろ過して化粧水を作製した。
(Example 3) Lotion by weight (alcohol phase) Saikosaponin b 1 0.05 Bacyl alcohol 4.0 Ethanol 7.0 Polyoxyethylene oleyl alcohol 0.6 Methyl paraben 0.05 Perfume 0.05 (Water Phase) Glycerin 4.0 Citric acid 0.01 Sodium citrate 0.1 Ion-exchanged water 84.14 (Preparation method) Prepare an aqueous phase and an alcohol phase, mix and solubilize them, and then filter to obtain lotion. Produced.

【0042】(実施例4) クリーム 重量% (油相) サイコサポニンb2 1.0 バチルアルコール 2.0 セトステアリルアルコール 3.5 スクワラン 38.0 ミツロウ 3.0 還元ラノリン 5.0 ステアリン酸エチル 2.0 エチルパラベン 0.3 香料 0.03 (水相) 1,3−ブチレングリコール 7.0 グリセリン 5.0 イオン交換水 33.17 (製法)油相を加熱融解して75℃に保ち、これを7
5℃に加温した水相に攪拌しながら加えた。次にホモミ
キサーで均一に乳化した後、攪拌しながら急冷してクリ
ームを得た。
(Example 4) Cream weight% (oil phase) Saikosaponin b 2 1.0 Bacyl alcohol 2.0 Cetostearyl alcohol 3.5 Squalane 38.0 Beeswax 3.0 Reduced lanolin 5.0 Ethyl stearate 2 0.0 Ethylparaben 0.3 Fragrance 0.03 (Aqueous phase) 1,3-butylene glycol 7.0 Glycerin 5.0 Ion-exchanged water 33.17 (Production method) Heat and melt the oil phase and keep it at 75 ° C. 7
It was added to the aqueous phase heated to 5 ° C. with stirring. Next, the mixture was uniformly emulsified with a homomixer and then rapidly cooled with stirring to obtain a cream.

【0043】(実施例5) パック 重量% サイコサポニンb1 0.01 バチルアルコール 9.0 ポリビニルアルコール 7.0 ポリエチレングリコール 3.0 プロピレングリコール 6.0 エタノール 10.0 メチルパラベン 0.05 香料 0.05 イオン交換水 64.89 (製法)イオン交換水にポリエチレングリコール、プ
ロピレングリコール、メチルパラベンを加え、攪拌溶解
した。次に、ポリビニルアルコールを加え加熱攪拌し、
サイコサポニンb1、バチルアルコール、香料を溶解し
たエタノールを加え、攪拌溶解してパックを得た。
(Example 5) Pack weight% saikosaponin b 1 0.01 Bacyl alcohol 9.0 Polyvinyl alcohol 7.0 Polyethylene glycol 3.0 Propylene glycol 6.0 Ethanol 10.0 Methyl paraben 0.05 Fragrance 0.05 Ion-exchanged water 64.89 (Production method) Polyethylene glycol, propylene glycol, and methylparaben were added to ion-exchanged water and dissolved by stirring. Next, add polyvinyl alcohol and heat and stir,
Psychosaponin b 1 , batyl alcohol, and ethanol in which a fragrance was dissolved were added, and the mixture was stirred and dissolved to obtain a pack.

【0044】(実施例6) 頭皮用化粧料 重量% (A相) サイコサポニンb1 0.5 1,3−ブチレングリコール 6.5 ポリエチレングリコール1500 5.0 エタノール 5.5 水酸化カリウム 0.05 イオン交換水 46.95 (B相) バチルアルコール 8.0 2−ヘキシルデシルパルミテート 2.0 スクワラン 5.0 ブチルパラベン 0.2 ビタミンEアセテート 0.15 香料 0.05 (C相) イオン交換水 19.9 カルボキシビニルポリマー 0.2 (製法)B相を75℃で溶解したものを、75℃に加
熱したA相に攪拌しながら添加し、更に室温で攪拌溶解
したC相をし、攪拌しながら冷却して頭皮用化粧料を得
た。
[0044] (Example 6) scalp cosmetics wt% (A phase) saikosaponins b 1 0.5 1,3-butylene glycol 6.5 polyethylene glycol 1500 5.0 Ethanol 5.5 Potassium hydroxide 0.05 Ion-exchanged water 46.95 (B phase) Bacyl alcohol 8.0 2-Hexyldecyl palmitate 2.0 Squalane 5.0 Butylparaben 0.2 Vitamin E acetate 0.15 Fragrance 0.05 (C phase) Ion-exchanged water 19.9 Carboxyvinyl polymer 0.2 (Preparation method) A solution prepared by dissolving phase B at 75 ° C was added to phase A heated to 75 ° C while stirring, and phase C dissolved by stirring at room temperature was further stirred. While cooling, a cosmetic for the scalp was obtained.

【0045】(実施例7) 軟膏 重量% サイコサポニンb2 4.0 バチルアルコール 20.0 ワセリン 35.0 ステアリルアルコール 15.0 モクロウ 15.0 ポリオキシエチレン(10)オレイル 0.5 アルコール イオン交換水 10.5 (製法)70℃のイオン交換水に70℃で混合溶解し
た他の成分を加え、ホモミキサーで均一乳化し、乳化後
冷却して軟膏を得た。
(Example 7) Ointment% by weight Saikosaponin b 2 4.0 Batyl alcohol 20.0 Vaseline 35.0 Stearyl alcohol 15.0 Mokurou 15.0 Polyoxyethylene (10) oleyl 0.5 alcohol Ion-exchanged water 10.5 (Preparation method) Other components mixed and dissolved at 70 ° C. in ion-exchanged water at 70 ° C. were added, uniformly emulsified by a homomixer, and emulsified and then cooled to obtain an ointment.

【0046】[0046]

【発明の効果】本発明により、すなわちサイコサポニン
1あるいはサイコサポニンb2にバチルアルコールを配
合することにより、サイコサポニンb1あるいはb2の有
する細胞増殖効果が向上し、しかも効果の経時的安定性
が改善される。その結果、長期間にわたり安定して高い
肌荒れ防止及び改善効果、皮膚老化防止効果または創傷
治癒効果を示す皮膚外用剤を提供することが可能とな
る。
According to the present invention, namely by blending batyl alcohol saikosaponins b 1 or saikosaponins b 2, increased cell proliferation effect possessed by saikosaponins b 1 or b 2, moreover temporal stability of effect Is improved. As a result, it is possible to provide a skin external preparation that exhibits a high effect of preventing and improving rough skin, an effect of preventing skin aging or an effect of healing wounds stably over a long period of time.

【図面の簡単な説明】[Brief description of the drawings]

【図1】サイコサポニンb1の細胞増殖効果がバチルア
ルコールにより向上する事を示すグラフである。
FIG. 1 is a graph showing that the cell growth effect of saikosaponin b 1 is improved by batyl alcohol.

【図2】サイコサポニンb1の細胞増殖効果の経時変化
を示すグラフである。
2 is a graph showing the time course of cellular proliferative effects of saikosaponins b 1.

【図3】赤血球の溶血がバチルアルコールの添加により
抑制される事を示すグラフである。
FIG. 3 is a graph showing that hemolysis of red blood cells is suppressed by the addition of batyl alcohol.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭61−7216(JP,A) 特開 昭49−55821(JP,A) 特開 昭57−197236(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-61-7216 (JP, A) JP-A-49-55821 (JP, A) JP-A-57-197236 (JP, A) (58) Field (Int.Cl. 7 , DB name) A61K 7/ 00-7/50 CA (STN) REGISTRY (STN)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 サイコサポニンb1とサイコサポニンb2
の少なくとも1種とバチルアルコールとを含有する皮膚
外用剤であり、 前記サイコサポニンb 1 及びサイコサポニンb 2 の少なく
とも1種を0.0001〜20重量%含む ことを特徴と
する皮膚外用剤。
1. Saikosaponin b 1 and saikosaponin b 2
Skin containing at least one and batyl alcohol
An external preparation, less the saikosaponins b 1 and saikosaponins b 2
An external preparation for skin characterized by containing 0.0001 to 20% by weight of at least one of them .
【請求項2】 前記バチルアルコールを0.01〜20
重量%含むことを特徴とする請求項1記載の皮膚外用
剤。
2. The method according to claim 1, wherein said batyl alcohol is contained in an amount of 0.01 to 20.
1 Symbol placement skin external preparation according to claim, characterized in that it comprises by weight%.
JP03195986A 1991-07-10 1991-07-10 External preparation for skin Expired - Lifetime JP3135295B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03195986A JP3135295B2 (en) 1991-07-10 1991-07-10 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03195986A JP3135295B2 (en) 1991-07-10 1991-07-10 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH0517335A JPH0517335A (en) 1993-01-26
JP3135295B2 true JP3135295B2 (en) 2001-02-13

Family

ID=16350316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03195986A Expired - Lifetime JP3135295B2 (en) 1991-07-10 1991-07-10 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3135295B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101832286B1 (en) * 2012-01-13 2018-02-26 주식회사 엘지생활건강 Composition for improving skin wrinkle and enhancing elasticity
CN115645294A (en) * 2022-09-30 2023-01-31 露乐健康科技股份有限公司 Application of batyl alcohol in preparation of product for treating female nipple discomfort during lactation and product for treating female nipple discomfort during lactation

Also Published As

Publication number Publication date
JPH0517335A (en) 1993-01-26

Similar Documents

Publication Publication Date Title
JP3251635B2 (en) External preparation for skin
JP2912489B2 (en) Skin cosmetics
JP2844103B2 (en) External preparation for skin
JP4138910B2 (en) Transdermal preparation containing azelastine hydrochloride with good transdermal absorbability and low skin irritation
JPS6267028A (en) Skin external preparation
JP3667027B2 (en) Topical skin preparation
JP2549119B2 (en) Topical
JP3135295B2 (en) External preparation for skin
JP3443130B2 (en) External preparation for skin
JP3135294B2 (en) External preparation for skin
JP2829157B2 (en) External preparation for skin
JP3135292B2 (en) External preparation for skin
JPH10279421A (en) Preparation for external use for skin
JP3135293B2 (en) External preparation for skin
JPH0517336A (en) Skin medicine for external use
JPH11302133A (en) Cosmetic for scalp and hair
JP3135296B2 (en) External preparation for skin
JP2531679B2 (en) Topical
JPH0469615B2 (en)
JPH0436137B2 (en)
JPH11116604A (en) External preparation for skin
JP3496896B2 (en) Hair restorer and hair cosmetic
JPH06321806A (en) External agent for skin
JPS60116616A (en) Cosmetic
JPH11180832A (en) Composition for scalp and hair

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20001114

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071201

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081201

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081201

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091201

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101201

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101201

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111201

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111201

Year of fee payment: 11